EFFECT OF ORAL ACTIVATED-CHARCOAL ON TOBRAMYCIN CLEARANCE

被引：7

作者：

DAVIS, RL

KOUP, JR

ROON, RA

OPHEIM, KE

SMITH, AN

机构：

[1] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195

[2] UNIV WASHINGTON,SCH PHARM,SEATTLE,WA 98195

[3] CHILDRENS HOSP & MED CTR,DIV INFECT DIS,SEATTLE,WA 98105

[4] CHILDRENS HOSP & MED CTR,DEPT LABS,SEATTLE,WA 98105

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 02期

关键词：

D O I：

10.1128/AAC.32.2.274

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：274 / 275

页数：2

共 18 条

[1]

[Anonymous], 1971, STAT PRINCIPLES EXPT

[2] ACCELERATION OF THE BODY CLEARANCE OF PHENOBARBITAL BY ORAL ACTIVATED-CHARCOAL [J].

BERG, MJ ;

BERLINGER, WG ;

GOLDBERG, MJ ;

SPECTOR, R ;

JOHNSON, GF .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (11) :642-644

[3] ENHANCEMENT OF THEOPHYLLINE CLEARANCE BY ORAL ACTIVATED-CHARCOAL [J].

BERLINGER, WG ;

SPECTOR, R ;

GOLDBERG, MJ ;

JOHNSON, GF ;

QUEE, CK ;

BERG, MJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :351-354

[4]

BURKE CM, 1983, CLIN PHARM THER, V34, P110

[5]

GADGIL SD, 1982, CANCER TREAT REP, V66, P1169

[6]

GIBALDI M, 1982, PHARMACOKINETICS

[7]

HALSTENSON CE, 1984, KIDNEY INT, V25, P256

[8] TREATMENT OF SALICYLATE POISONING WITH REPEATED ORAL CHARCOAL [J].

HILLMAN, RJ ;

PRESCOTT, LF .

BRITISH MEDICAL JOURNAL, 1985, 291 (6507) :1472-1472

[9] PHARMACOKINETICS OF TOBRAMYCIN IN PATIENTS WITH STABLE RENAL IMPAIRMENT, PATIENTS UNDERGOING PERITONEAL-DIALYSIS, AND PATIENTS ON CHRONIC HEMODIALYSIS [J].

JAFFE, G ;

MEYERS, BR ;

HIRSCHMAN, SZ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 5 (06) :611-616

[10]

KARKKAINEN S, 1985, INT J CLIN PHARM TH, V23, P219

← 1 2 →